| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |